glp-1 dpp 4 combination DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner Frontiers | Mechanisms of action

Novo already operates large plants in Denmark and in Clayton for insulin

This study is, to the best of the authors knowledge, the first systematic integration of FA metabolic derangements with GA pathogenesis and therapeutic development

The Wait is Almost Over In two days, we are launching superPeptide GHK-Cu + HA Pro-Collagen Serum

A laboratory study simulating IV therapy found that plastic IV infusion products (such as infusion bottles/bags and tubes) used to deliver 1 liter of IV fluid may expose the body to 57,500 particles of polyvinyl chloride microplastics and 686 particles of polyethylene-polypropylene microplastics (Li, J Hazard Mater 2025)

Hesperidin possesses antioxidant, anti-inflammatory, cardioprotective, anti-allergic, and neuroprotective properties

Future studies could bring out all the benefits and eventually be incorporated as targeted therapies in hyperpigmentation diseases, which would help in patients' treatment processes.